SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries
SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries
复制标题
DOI：
10.1002/pbc.24468
复制
发表时间：
2013-05-01
影响因子：
3.2
通讯作者：
Doz, Francois
中科院分区：
文献类型：
--
作者：
Chantada, Guillermo;Luna-Fineman, Sandra;Doz, Francois
视网膜母细胞瘤在世界许多地区仍然无法治愈。治愈的主要障碍是延迟诊断，治疗依从性差，缺乏临床管理的循证建议。虽然眼球摘除术可以治愈眼内疾病，但在发展中国家，视网膜母细胞瘤通常是在疾病扩散到眼睛以外之后才被诊断出来。SIOP-PODC委员会制定了发展中国家视网膜母细胞瘤临床管理指南，并根据这些环境中可用的资源开发了一个分类系统。建议提供分期和治疗的单侧和双侧视网膜母细胞瘤和咨询的家庭谁遵守是一个问题。儿科血液癌症2013; 60：719727。(c)2013 Wiley Periodicals，Inc.
Retinoblastoma remains incurable in many regions of the world. The major obstacles to cure are delayed diagnosis, poor treatment compliance, and lack of evidence-based recommendations for clinical management. Although enucleation is curative for intraocular disease, in developing countries retinoblastoma is often diagnosed after the disease has disseminated beyond the eye. A SIOP-PODC committee generated guidelines for the clinical management of retinoblastoma in developing countries and developed a classification system based on the resources available in those settings. Recommendations are provided for staging and treatment of unilateral and bilateral retinoblastoma and counseling of families for whom compliance is an issue. Pediatr Blood Cancer 2013; 60: 719727. (c) 2013 Wiley Periodicals, Inc.